How should the mainland learn from the "experience of drug market" in Hong Kong?

According to the people's daily, Herceptin of the same specification is more than 10000 yuan more expensive in the mainland than in Hong Kong The price of drugs in Hong Kong is generally much cheaper than that in the mainland Hong Kong people familiar with the matter said that the low price of drugs was due to the fact that there was no middle exploitation and separation between the pharmaceutical companies and patients In fact, Hong Kong's experience is not complicated: first, it adheres to the separation of medicine, directly taking medicine, unified procurement and original price sales; third, it ensures that doctors adhere to integrity by combining high salary with severe punishment; second, it is a mature internal check and balance mechanism of hospitals, as well as the self purification and self-discipline tradition of societies and industry groups How much can the mainland learn from all this? And the mainland's much criticized "medicine for medical care" dominates the basic order of the medical system "For survival" has become the reason for hospitals and doctors to earn the drug price difference crazily; at the same time, the insufficient investment of public finance in the medical cause has given the legitimacy of "supporting doctors with drugs" In addition, in the mainland pharmaceutical sales system, many intermediate links increase the channel cost of drugs And some mainland doctors who are busy with "income generation", from values to practical actions, have abandoned the sacred sense of doctors There is no doubt that there is a strong barrier between the mainland model and the Hong Kong experience In this regard, even though there have been many complaints in recent years, there are also some pilot reforms, but they have had little effect.